ALSO READJubilant Life Sciences surges 12% on robust March quarter earnings Jubilant Life Sciences hikes prices by up to 15% on select products Jubilant Life up over 5% as arm signs contracts in Radiopharma business Technical calls: Buy SCI, Indiabulls Housing and Jubilant Life Jubilant Life, Syngene International, Essel Propack, Shemaroo hit 52-week high
The stock jumped 6.60 per cent to settle at Rs 723 on BSE. Intra-day, it surged 12.45 per cent to Rs 762.70.
At NSE, shares of the company gained 7 per cent to close at Rs 723.30.
The company's market valuation went up by Rs 713 crore to Rs 11,516.03 crore.
Consolidated total revenue from operations also rose to Rs 1,641.42 crore for the quarter under consideration as against Rs 1,515.83 crore for the same period a year ago.
For the fiscal year ended March this year, the net profit of the company rose to Rs 574.62 crore as against Rs 386.82 crore a year ago.